BIOLASE Inc represents values of innovation, excellence, and patient-centric care. With a strong corporate philosophy focused on transforming dental procedures, BIOLASE Inc is a leading dental laser technology company. They aim to deliver cutting-edge solutions that improve patient outcomes and enhance the dental experience. By leveraging their advanced products, such as Waterlase dental lasers, BIOLASE Inc enables minimally invasive and precise treatments, minimizing pain and promoting faster recovery. With a relentless commitment to research and development, BIOLASE Inc constantly pushes the boundaries of dental technology to ensure optimal oral health for patients worldwide.

BIOLASE Inc is primarily present in the United States.

BIOLASE Inc has achieved several significant milestones since its inception. The company pioneered the development and commercialization of dental laser systems, revolutionizing the dental industry. They introduced the world's first dental laser, the Waterlase system, which offers minimally invasive and precise treatments. Moreover, BIOLASE has gained FDA approvals for various dental laser applications, expanding their product portfolio. They have also established partnerships with renowned dental organizations and institutions worldwide. Additionally, BIOLASE has received multiple awards and accolades for its innovative technologies and contributions to the dental field. These achievements solidify BIOLASE Inc's position as a leading provider of dental laser systems and reinforce their commitment to advancing patient care.

BIOLASE Inc is a renowned company in the field of dental lasers and imaging technology. Established in 1987, it has garnered a strong reputation for its innovative products and solutions. With a focus on improving dental treatments, BIOLASE has developed advanced laser systems that revolutionize dental procedures. The company's commitment to research and development has led to numerous patented technologies, making BIOLASE a leader in the industry. Over the years, BIOLASE Inc has significantly contributed to the dental healthcare sector and continues to provide cutting-edge solutions for better patient outcomes.

The main competitors of BIOLASE Inc in the market are Dentsply Sirona Inc, Zimmer Biomet Holdings Inc, and Straumann Holding AG.

BIOLASE Inc is primarily active in the dental industry.

The business model of BIOLASE Inc revolves around developing, manufacturing, and marketing innovative dental laser systems. BIOLASE aims to provide superior solutions for dental practitioners worldwide, enabling minimally invasive and more efficient dental procedures. Known for their flagship product, Waterlase, BIOLASE utilizes laser technology to deliver precise and gentle dental treatments, reducing the need for drills, anesthesia, and pain. With a focus on improving patient care and outcomes, BIOLASE's business model centers on advancing dental laser technology and expanding their market presence through strategic partnerships and continuous innovation.

مُعامل القيمة السوقية إلى الأرباح لـ BIOLASE هو ؜-٠٫٠٠.

مُعامِل القيمة إلى المبيعات BIOLASE هو ٠٫٠٠.

نقاط جودة AlleAktien لـ BIOLASE هي 4/10.

المتوقعة BIOLASE الإيرادات هي ٥٠٫٤٩ مليون. USD.

صافي الربح المتوقعة BIOLASE هو ؜-١٦٫٤٣ مليون. USD.

BIOLASE Inc is a leading company in medical technology that specializes in the development, manufacturing, and marketing of laser systems for dentistry and other medical applications. The company was founded in 1987 and is headquartered in Irvine, California. BIOLASE's focus is on developing dental lasers that enable gentle and pain-free treatment of patients. The main division of BIOLASE is the development of laser systems for dentistry. The company offers a wide range of products such as Waterlase systems, Epic diode lasers, and diagnostic equipment. The Waterlase systems use water and laser energy to soften tooth hardness and enable pain-free treatment. The Epic diode lasers specialize in the treatment of gum diseases and provide a fast and effective treatment method. The diagnostic equipment allows for accurate diagnosis of dental problems and thus speeds up the healing process. BIOLASE is also active in other medical fields, such as pain and inflammation treatment. The company offers a variety of laser systems that can be used in pain treatment and inflammation reduction. These systems are capable of targeting specific areas in the body, leading to faster and more effective healing. Another business area of the company is research and development of new technologies. BIOLASE heavily invests in the development of new laser systems and technologies to expand treatment options for dentists and other medical professionals. The company works closely with doctors and dentists to understand customer requirements and needs and to find innovative solutions that meet the needs of patients. BIOLASE also operates an extensive network of distribution partners and distribution centers in various countries worldwide. The company has built a global distribution network to ensure that its products are available in different markets worldwide. BIOLASE works closely with its distribution partners to ensure that its customers receive the best products and services. Overall, BIOLASE Inc is a leading company in medical technology that specializes in the development and marketing of laser systems for dentistry and other medical applications. The company is at the forefront of developing new and innovative technologies and works closely with its customers and distribution partners to provide the best possible products and services.

يوزع BIOLASE أرباحًا قدرها 0 USD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ BIOLASE في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـBIOLASE هو US0909112072.

رمز WKN لـ BIOLASE هو 894190.

الرمز المُختصر لـ BIOLASE هو BIOL.

خلال آخر 12 شهراً، دفعت BIOLASE توزيعات أرباح بقيمة ٠٫١٤ USD . وهذا يعادل عائد توزيعات أرباح يقارب ٣٬٠٦٢٫٦٦ %. ومن المتوقع أن تدفع BIOLASE خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ0 USD.

نسبة توزيعات الأرباح الحالية لـ BIOLASE هي ٣٬٠٦٢٫٦٦ %.

BIOLASE يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يناير, مارس, مايو, يوليو.

BIOLASE دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة 0 USD. وهذا يعادل عائد توزيعات أرباح قدره 0 %.

BIOLASE يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٠١ USD من BIOLASE المُعلن عنها في ١٢‏/٧‏/٢٠٠٥، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٤‏/٦‏/٢٠٠٥.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٢‏/٧‏/٢٠٠٥.

في العام 2023، وزعت BIOLASE 0 USD كأرباح أسهم.

يتم توزيع أرباح BIOLASE بالعملة USD.